Nuacht

FDA announces change to future Covid-19 vaccine approvals that will limit fall boosters
The agency is changing the standard of evidence required for Covid-19 vaccine approval in the US, Dr. Vinay Prasad, the new ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
STAT8 nóiméad
FDA will limit Covid vaccines to people over 65 or at high risk of serious illness, leaders say
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
PharmTech21 uair an chloig
EMA Recommends Update to COVID-19 Vaccines for 2025-26 Campaign
The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...
Healio28 nóiméad
FDA will restrict future COVID-19 vaccines based on age, risk factors
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
F.D.A. Poised to Restrict Access to Covid Vaccines
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
Tampa Free Press on MSN1 uair an chloig
FDA Overhauls COVID-19 Vaccine Approval Process, Shifting Focus To High-Risk Individuals
The U.S. Food and Drug Administration (FDA) is set to significantly alter its approach to approving COVID-19 vaccines, a move ...
New Trump vaccine policy limits access to COVID shots
It comes as Health Secretary Robert F. Kennedy Jr. and his appointees continue to scrutinize the use of vaccines for a number ...
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
WebMD2 uair an chloig
FDA Approves Novavax COVID Vaccine With Restricted Use
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.